Dutch Bros Inc

BROS is in a Stage 2 advancing regime within a healthy uptrend, supported by rising EMAs and a clear higher-high/higher-low sequence. Price is currently pulling back into the 9- and 21-day EMA zone and holding, offering a favorable entry for continuation participation. Moderate Stage Transition Risk and overbought context warrant vigilance if EMA support fails.

• ↑Q1 revenue $464 M (+31% YoY) with adj. EBITDA $79 M (+26%)
• ↑Analysts project EPS $0.29 next quarter (+11.5% YoY) on positive revisions
• ↓~60 bps COGS hit from elevated coffee prices; CFO foresees 200 bps margin headwind